The stock of Gamida Cell Ltd (GMDA) has seen a -9.42% decrease in the past week, with a -90.67% drop in the past month, and a -90.38% decrease in the past quarter. The volatility ratio for the week is 30.13%, and the volatility levels for the past 30 days are at 18.83% for GMDA. The simple moving average for the past 20 days is -87.40% for GMDA’s stock, with a -95.75% simple moving average for the past 200 days.
Is It Worth Investing in Gamida Cell Ltd (NASDAQ: GMDA) Right Now?
GMDA has 36-month beta value of 0.96. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GMDA is 116.93M, and currently, short sellers hold a 8.54% ratio of that float. The average trading volume of GMDA on April 08, 2024 was 9.27M shares.
GMDA) stock’s latest price update
The stock price of Gamida Cell Ltd (NASDAQ: GMDA) has plunged by -18.25 when compared to previous closing price of 0.04, but the company has seen a -9.42% decline in its stock price over the last five trading sessions. InvestorPlace reported 2024-03-27 that Gamida Cell (NASDAQ: GMDA ) stock is falling hard on Wednesday after the clinical-stage biopharmaceutical company announced major changes to its business in its Q4 earnings report. This big news here is the company entering into a Restructuring Support Agreement (RSA) with funds managed by Highbridge Capital Management.
Analysts’ Opinion of GMDA
Many brokerage firms have already submitted their reports for GMDA stocks, with Alliance Global Partners repeating the rating for GMDA by listing it as a “Buy.” The predicted price for GMDA in the upcoming period, according to Alliance Global Partners is $11 based on the research report published on November 01, 2021 of the previous year 2021.
Piper Sandler gave a rating of “Overweight” to GMDA, setting the target price at $13 in the report published on May 26th of the previous year.
GMDA Trading at -90.05% from the 50-Day Moving Average
After a stumble in the market that brought GMDA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.70% of loss for the given period.
Volatility was left at 18.83%, however, over the last 30 days, the volatility rate increased by 30.13%, as shares sank -90.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -90.66% lower at present.
During the last 5 trading sessions, GMDA fell by -9.42%, which changed the moving average for the period of 200-days by -98.31% in comparison to the 20-day moving average, which settled at $0.2442. In addition, Gamida Cell Ltd saw -92.08% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GMDA
Current profitability levels for the company are sitting at:
- -40.72 for the present operating margin
- -0.5 for the gross margin
The net margin for Gamida Cell Ltd stands at -36.09. The total capital return value is set at -0.94. Equity return is now at value -1103.79, with -55.51 for asset returns.
Based on Gamida Cell Ltd (GMDA), the company’s capital structure generated 1.04 points at debt to capital in total, while cash flow to debt ratio is standing at -0.97. The debt to equity ratio resting at -27.4. The interest coverage ratio of the stock is -5.1.
Currently, EBITDA for the company is -70.62 million with net debt to EBITDA at -0.47. When we switch over and look at the enterprise to sales, we see a ratio of 21.12. The receivables turnover for the company is 1.11for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.16.
Conclusion
To put it simply, Gamida Cell Ltd (GMDA) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
